David A. Siegel Veracyte, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Veracyte, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,600 shares of VCYT stock, worth $362,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600
Previous 15,300
24.18%
Holding current value
$362,268
Previous $520,000
11.73%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$256 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$243 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$206 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$131 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$128 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.24B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...